Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11920608rdf:typepubmed:Citationlld:pubmed
pubmed-article:11920608lifeskim:mentionsumls-concept:C0007102lld:lifeskim
pubmed-article:11920608lifeskim:mentionsumls-concept:C0334227lld:lifeskim
pubmed-article:11920608lifeskim:mentionsumls-concept:C0288331lld:lifeskim
pubmed-article:11920608lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:11920608lifeskim:mentionsumls-concept:C0332157lld:lifeskim
pubmed-article:11920608lifeskim:mentionsumls-concept:C0449438lld:lifeskim
pubmed-article:11920608lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:11920608lifeskim:mentionsumls-concept:C0376515lld:lifeskim
pubmed-article:11920608lifeskim:mentionsumls-concept:C0079419lld:lifeskim
pubmed-article:11920608lifeskim:mentionsumls-concept:C0332287lld:lifeskim
pubmed-article:11920608lifeskim:mentionsumls-concept:C1332397lld:lifeskim
pubmed-article:11920608lifeskim:mentionsumls-concept:C0683598lld:lifeskim
pubmed-article:11920608lifeskim:mentionsumls-concept:C0205345lld:lifeskim
pubmed-article:11920608lifeskim:mentionsumls-concept:C1707520lld:lifeskim
pubmed-article:11920608lifeskim:mentionsumls-concept:C0443252lld:lifeskim
pubmed-article:11920608pubmed:issue4lld:pubmed
pubmed-article:11920608pubmed:dateCreated2002-3-28lld:pubmed
pubmed-article:11920608pubmed:abstractTextDefects in apoptosis have been implicated in chemoresistance of colon cancer cells. We report here the ability to resist to 5-fluorouracil-induced apoptosis of 8 colon cancer cell lines differing in p53 and bax status: p53(-/0)bax(+/+) for TC7, SW480, HT-29; p53(+/+)bax(-/-) for LS174T, LoVo; p53(+/+) bax(+/-) for HCT116; p53(+/+) or p53(+/0)bax(+/+) for LS513 or HCT-EB, respectively. To approximate to the in vivo therapy, the cell lines were exposed to a long-term treatment of 5-FU. The analysis of proteins implicated in the apoptotic pathway has shown that the independent analysis of p53 or bax status was not sufficient to predict the extent of drug-resistance of all cell lines. In p53(+/+) cell lines but not in p53(-/0) cell lines, a low level of the pro-apoptotic Bax protein was correlated with a greater resistance of cells to 5-FU. In addition, we found that high levels of anti-apoptotic Bcl-2 and Bcl-x(L) proteins combined with a low level of Bax were correlated to high 5-FU resistance of wild-type p53 cell lines. The same correlation was obtained for 2 out of 3 mutated p53 cell lines. In conclusion, the relative levels of Bcl-2, Bcl-x(L) and Bax may altogether contribute to determine the resistance of a majority of colon tumor cells to long-term 5-FU treatment, whatever their p53 status.lld:pubmed
pubmed-article:11920608pubmed:languageenglld:pubmed
pubmed-article:11920608pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11920608pubmed:citationSubsetIMlld:pubmed
pubmed-article:11920608pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11920608pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11920608pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11920608pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11920608pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11920608pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11920608pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11920608pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11920608pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11920608pubmed:statusMEDLINElld:pubmed
pubmed-article:11920608pubmed:monthAprlld:pubmed
pubmed-article:11920608pubmed:issn0020-7136lld:pubmed
pubmed-article:11920608pubmed:authorpubmed-author:PoulainLauren...lld:pubmed
pubmed-article:11920608pubmed:authorpubmed-author:StaedelCathyClld:pubmed
pubmed-article:11920608pubmed:authorpubmed-author:ChambazJeanJlld:pubmed
pubmed-article:11920608pubmed:authorpubmed-author:LacorteJean-M...lld:pubmed
pubmed-article:11920608pubmed:authorpubmed-author:VioletteSabin...lld:pubmed
pubmed-article:11920608pubmed:authorpubmed-author:DussaulxElisa...lld:pubmed
pubmed-article:11920608pubmed:authorpubmed-author:PepinDominiqu...lld:pubmed
pubmed-article:11920608pubmed:authorpubmed-author:FaussatAnne-M...lld:pubmed
pubmed-article:11920608pubmed:authorpubmed-author:LesuffleurThé...lld:pubmed
pubmed-article:11920608pubmed:copyrightInfoCopyright 2002 Wiley-Liss, Inc.lld:pubmed
pubmed-article:11920608pubmed:issnTypePrintlld:pubmed
pubmed-article:11920608pubmed:day1lld:pubmed
pubmed-article:11920608pubmed:volume98lld:pubmed
pubmed-article:11920608pubmed:ownerNLMlld:pubmed
pubmed-article:11920608pubmed:authorsCompleteYlld:pubmed
pubmed-article:11920608pubmed:pagination498-504lld:pubmed
pubmed-article:11920608pubmed:dateRevised2007-7-24lld:pubmed
pubmed-article:11920608pubmed:meshHeadingpubmed-meshheading:11920608...lld:pubmed
pubmed-article:11920608pubmed:meshHeadingpubmed-meshheading:11920608...lld:pubmed
pubmed-article:11920608pubmed:meshHeadingpubmed-meshheading:11920608...lld:pubmed
pubmed-article:11920608pubmed:meshHeadingpubmed-meshheading:11920608...lld:pubmed
pubmed-article:11920608pubmed:meshHeadingpubmed-meshheading:11920608...lld:pubmed
pubmed-article:11920608pubmed:meshHeadingpubmed-meshheading:11920608...lld:pubmed
pubmed-article:11920608pubmed:meshHeadingpubmed-meshheading:11920608...lld:pubmed
pubmed-article:11920608pubmed:meshHeadingpubmed-meshheading:11920608...lld:pubmed
pubmed-article:11920608pubmed:meshHeadingpubmed-meshheading:11920608...lld:pubmed
pubmed-article:11920608pubmed:meshHeadingpubmed-meshheading:11920608...lld:pubmed
pubmed-article:11920608pubmed:meshHeadingpubmed-meshheading:11920608...lld:pubmed
pubmed-article:11920608pubmed:meshHeadingpubmed-meshheading:11920608...lld:pubmed
pubmed-article:11920608pubmed:meshHeadingpubmed-meshheading:11920608...lld:pubmed
pubmed-article:11920608pubmed:meshHeadingpubmed-meshheading:11920608...lld:pubmed
pubmed-article:11920608pubmed:meshHeadingpubmed-meshheading:11920608...lld:pubmed
pubmed-article:11920608pubmed:meshHeadingpubmed-meshheading:11920608...lld:pubmed
pubmed-article:11920608pubmed:meshHeadingpubmed-meshheading:11920608...lld:pubmed
pubmed-article:11920608pubmed:year2002lld:pubmed
pubmed-article:11920608pubmed:articleTitleResistance of colon cancer cells to long-term 5-fluorouracil exposure is correlated to the relative level of Bcl-2 and Bcl-X(L) in addition to Bax and p53 status.lld:pubmed
pubmed-article:11920608pubmed:affiliationINSERM U505, Université Pierre et Marie Curie, Paris, France.lld:pubmed
pubmed-article:11920608pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11920608pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:12048entrezgene:pubmedpubmed-article:11920608lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:11920608lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11920608lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11920608lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11920608lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11920608lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11920608lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11920608lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11920608lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11920608lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11920608lld:pubmed